Modern Dental Group Ltd (3600) Fair Value & Analysis
Healthcare · HK · Market cap HK$5.8B
Fair value as of: Aug 13, 2026
From 26 valuation models · updated 3 days ago
Share price +7.5% over the past month.
A strong business, screening 60% undervalued on our models.
What matters now
- The rarer combination: high quality (78/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (HK$8.99). The market is more pessimistic than our downside scenario.
- A fairly wide model range (HK$8.99 to HK$16.48) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$1.41 – HK$8.42 · fair‑value band HK$8.99 – HK$16.48 · the HK$8.28 price screens below the HK$13.21 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Modern Dental Group Ltd (3600) currently trades at HK$8.28, while our model-based Fair Value estimate is HK$13.21, implying the stock looks roughly 59.5% undervalued today. The Quality Score stands at 78/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Modern Dental Group Ltd generated revenue of HK$3.7B at a net margin of 16.0%. Revenue grew 14.4% year over year. It earns a return on equity of 20.0%. The balance sheet holds a net cash position of HK$113M. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$8.99 (bear case) to HK$16.48 (bull case); at HK$8.28, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 111% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at 60%, 3600 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (HK$15.17) versus Asset-Based (HK$2.36). Highest evidence: Growth DCF (80).
Notify me when 3600 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 76 · Market factors (momentum, volatility) 86
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Modern Dental Group Limited, an investment holding company, engages in production, distribution, and trading of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. The company operates through three segments: Fixed Prosthetic Devices; Removable Prosthetic Devices; and Others.
Full company description
Modern Dental Group Limited, an investment holding company, engages in production, distribution, and trading of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. The company operates through three segments: Fixed Prosthetic Devices; Removable Prosthetic Devices; and Others. It offers restorative dental procedures, such as crowns, bridges, and implants. The company also produces full and partial dentures with and without metal frameworks. In addition, it offers orthodontic devices, sports guards, anti-snoring devices, raw materials, clear aligner, and dental equipment; and services for educational events and seminars. The company sells its products under the Labocast, Permadental, Elysee, Yangzhijing, Modern Dental Laboratory, Modern Dental USA, and Southern Cross Dental brands. Modern Dental Group Limited was founded in 1986 and is based in Cheung Sha Wan, Hong Kong
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Modern Dental Group Ltd reported revenue of HK$3.7B in FY2025 versus HK$3.0B in FY2021, a compound +6.0%/yr. Reported net income was HK$597M in FY2025, compounding +13.4%/yr from FY2021.
of which total revenue +10.3 pp · buybacks/dilution −1.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch 3600: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 202 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $181.41 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare Modern Dental Group Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Modern Dental Group Ltd (3600) overvalued or undervalued?
What is the fair value of 3600?
What is the quality score of 3600?
What is the revenue of Modern Dental Group Ltd (3600)?
What is the net profit margin of 3600?
Does Modern Dental Group Ltd pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Modern Dental Group Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.